The Philip Ahern lab studies the intestinal immune system, gut microbiota, and how they influence inflammatory bowel disease.
The Kathleen Berkner lab studies gamma-glutamyl carboxylation of vitamin K-dependent proteins.
The J. Mark Brown lab studies the relationship between diet, microbe, host metabolism and chronic cardiometabolic disease.
The Scott Cameron lab researches blood platelet reprogramming for vascular and thrombotic disorders.
The Cathcart lab studies mechanisms responsible for LDL and lipid oxidation during the activation of human monocytes and the role of lipids in regulating HM activation and migration into sites of inflammation.
The Olga Cherepanova lab studies phenotypic transition of vascular cells during atherosclerosis development and after injury.
The Jan Claesen lab studies bacterial interspecies and microbe-host interactions in the microbiome.
The Paul Fox lab studies IFN-gamma signaling, mechanisms of blood vessel formation and ferroxidases in iron metabolism.
The Lynn Hajjar lab studies how microbiota alter immune responses and impact health and disease.
The Stanley Hazen lab studies how inflammation contributes to cardiovascular diseases and the microbiome’s role in heart health.
The Christopher Hine lab explores the relationship between aging, nutrition, metabolism and stress resistance.
The Elaine Husni lab studies outcomes in rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and osteoarthritis.
The Jacobsen lab investigates the mechanism of homocysteine toxicity and its role in atherosclerosis.
The Sadashiva Karnik lab AT1R structure, function, physiology, genetics and signaling.
The Justin Lathia lab studies how cancer stem cells in glioblastoma interact with their surrounding microenvironment.
The Byron Lee lab studies chromatin modifier mutations in urothelial cancers of the bladder and upper tract.
The Luse lab studies molecular events that drive promoter recognition and transcription of genes in chromosomes.
The Keith McCrae lab studies the function of blood vessels in health and disease.
The McIntyre lab studies how cells respond to external stimuli, specifically in the vascular system.
The Aaron Miller lab studies diet, microbiome and host factors in chronic urologic disease and co-morbidities.
The Christine Moravec lab investigates physiological and biomechanical changes and psychophysiologic remodeling in heart failure.
The Ina Nemet lab focuses on understanding the communication between gut microorganisms and their host.
The Richard Padgett lab focuses on mechanisms of post-transcriptional RNA processing, particularly pre-mRNA splicing.
The Perez lab discerns the roles of α1-adrenergic receptor subtypes in physiological and pathophysiological states.
The Edward Plow lab studies the central properties of integrins in inflammation and angiogenesis.
The Prasad lab studies protein regulation and how it may be targeted for new heart failure treatments.
The Jun Qin lab studies key protein-protein interactions in heart failure, diabetes and cancer.
The Reizes lab studies ovarian cancer and triple negative breast cancer, focusing on novel therapeutic development.
The Schumacher-Bass lab investigates heart failure and signaling mechanisms, including G protein-coupled receptors.
The Jonathan Smith lab studies cardiovascular diseases including atherosclerosis, atrial fibrillation and HDL metabolism.
The Apollo Stacy Lab focuses on the characterization of polymicrobial-host interactions within the oral cavity that regulate susceptibility to disease.
The Stenina Adognravi lab investigates vascular complications of diabetes due to hyperglycemia.
The Wilson Tang lab studies determinants of cardiovascular disease, particularly in human heart failure and cardiomyopathy.
The Van Wagoner lab studies how genetic variations lead to increased risk of atrial fibrilation.
The Oliver Wessely lab studies kidney development and diseases.